Difficulty in terminating the preceding movement/posture explains the impaired initiation of new movements in...

Area of Science:

• Neuroscience
• Movement Disorders
• Clinical Neurology

Background:

• Parkinson's disease (PD) is characterized by motor symptoms, including bradykinesia.
• The precise cause of movement initiation difficulty in PD remains debated.
• Distinguishing between impaired movement termination and impaired movement initiation is crucial for understanding PD pathophysiology.

Purpose of the Study:

• To investigate whether the difficulty in initiating volitional movements in Parkinson's disease is due to impaired termination of preceding movements/postures or impaired initiation of new movements.
• To assess the impact of disease stage on these motor control deficits.

Main Methods:

• Patients with Parkinson's disease and age-matched controls performed eye and wrist movement tasks under two conditions: overlap (requiring termination of fixation/positioning) and gap (allowing proactive termination).
• Ocular and manual movement latencies were analyzed in both conditions.
• The contribution of movement termination difficulty was evaluated by normalizing latency differences between conditions based on control performance and correlating with Parkinson's disease stage.

Main Results:

• Movement latencies were prolonged in the overlap task compared to the gap task for both Parkinson's disease patients and controls.
• The latency prolongation in the overlap task, relative to the gap task, increased exponentially with Parkinson's disease stage.
• This suggests that difficulty in terminating existing fixation/wrist positioning significantly contributes to movement initiation problems, especially in later stages of Parkinson's disease.

Conclusions:

• The findings indicate that impaired termination of preceding movements/postures is a primary contributor to the difficulty in initiating volitional movements in Parkinson's disease.
• This deficit in movement termination becomes more pronounced as Parkinson's disease progresses.
• Understanding this distinction is vital for developing targeted therapeutic strategies for Parkinson's disease motor symptoms.